Here’s what you should know:
1. Dr. Wilkinson was recognized for his high level of training and experience with NeoTract’s UroLift System. He uses the system to treat symptoms associated with benign prostatic hyperplasia.
2. Dr. Wilkinson said he was proud of the designation and the improvements the use of UroLift makes to his patients’ lives.
3. The UroLift system provides BPH patients relief. According to randomized study data, patients treated with the UroLift system experienced symptom relief with minimal side effects, the press release notes.
4. Dr. WIlkinson said, “The UroLift System is revolutionary treatment that allows me to treat men in my office under local anesthesia. Unlike more invasive options, the UroLift System provides men relief from their bothersome symptoms within days following the procedure.”
More articles on leadership:
After 47-year moratorium, Massachusetts has 1st new ASC — 5 insights
3 ASCs, Cigna settle alleged ERISA violation suit
Healthcare Re, Muve Health roll out 1st prospective bundle reinsurance policy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.